CUREVAC Trademark

Trademark Overview


On Tuesday, September 3, 2019, a trademark application was filed for CUREVAC with the United States Patent and Trademark Office. The USPTO has given the CUREVAC trademark a serial number of 88602178. The federal status of this trademark filing is REGISTERED as of Tuesday, April 13, 2021. This trademark is owned by CureVac AG. The CUREVAC trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Chemical preparations for medical use, namely, for therapeutic and prophylactic treatment of neurological, neuromuscular, neurodegenerative, infectious and cardiovascular diseases, of autoimmune diseases and cancer diseases, of tumours, of allergies, of metabolic diseases, of heritable genetic diseases, and for therapies replacing proteins or enzymes; pharmaceutical preparations, namely, immunostimulants, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, vaccines, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, adjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromolecules, in particular for human or veterinary purposes for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment of infectious diseases, autoimmune diseases and tumours, for treatment of cancers, for treatment of metabolic diseases and for treatment...

Chemical reagents and biomolecules, in particular biological macromolecules, for industrial or scientific purposes; Reagents for research purposes

Medical and veterinary services, in particular for therapeutic and prophylactic treatment of cancer diseases, infectious diseases, autoimmune diseases or allergies; Medical and veterinary services for treating of hereditary disorders; Medical and veterinary services for protein or enzyme supplement therapy for therapeutic or prophylactic treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases and for treatment of endocrinological or metabolic disorders

Scientific and technological services and research, in particular scientific research for identification, testing and characterisation of biological macromolecules; medical testing services, namely, pre-clinical and clinical testing of macromolecules; scientific research in the nature of discovery of biological macromolecules; Laboratory services, related to custom manufacturing of pharmaceutical ingredients, for identification, testing and characterisation of biological macromolecules
curevac

General Information


Serial Number88602178
Word MarkCUREVAC
Filing DateTuesday, September 3, 2019
Status700 - REGISTERED
Status DateTuesday, April 13, 2021
Registration Number6318156
Registration DateTuesday, April 13, 2021
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 26, 2021

Trademark Statements


Description of MarkThe mark consists of the stylized term "CUREVAC" with the term "CURE" appearing in orange, the term "VAC" appearing in blue, and with a blue curved line beginning at the letter "V", and extending to the right and below the wording.
Certificate of Correction for RegistrationIn the statement, line 2, "Paul-Ehrlich-Str. 15" should be deleted, and "Friedrich-Miescher-Str. 15" should be inserted.
Goods and ServicesChemical preparations for medical use, namely, for therapeutic and prophylactic treatment of neurological, neuromuscular, neurodegenerative, infectious and cardiovascular diseases, of autoimmune diseases and cancer diseases, of tumours, of allergies, of metabolic diseases, of heritable genetic diseases, and for therapies replacing proteins or enzymes; pharmaceutical preparations, namely, immunostimulants, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, vaccines, in particular for human or veterinary medical purposes; pharmaceutical preparations, namely, adjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromolecules, in particular for human or veterinary purposes for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for the treatment of infectious diseases, autoimmune diseases and tumours, for treatment of cancers, for treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; gene therapy products, namely, nucleic acid macromolecules for in vivo expression for human or veterinary medical use; Dietetic substances adapted for medical use, in particular substances for food supplements, namely, dietary food supplements; Peptide carrier molecules for association with a biological macromolecule, for medical use, namely, for use in facilitating delivery of a wide range of medicinal substances; Peptidic carrier molecule for preparing a pharmaceutical composition, namely, for medical use as a protein delivery preparation to expedite or improve delivery of a therapeutic macromolecule or prophylactic biological marcomolecule; Peptide carrier molecule, sold in combination with a biological macromolecule for preparing a pharmaceutical composition, namely, for medical use as a protein delivery preparation to expedite or improve delivery of a therapeutic drug or prophylactic drug
Pseudo MarkCURE VAC
Indication of Colors claimedThe color(s) orange and blue is/are claimed as a feature of the mark.
Goods and ServicesChemical reagents and biomolecules, in particular biological macromolecules, for industrial or scientific purposes; Reagents for research purposes
Goods and ServicesMedical and veterinary services, in particular for therapeutic and prophylactic treatment of cancer diseases, infectious diseases, autoimmune diseases or allergies; Medical and veterinary services for treating of hereditary disorders; Medical and veterinary services for protein or enzyme supplement therapy for therapeutic or prophylactic treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases and for treatment of endocrinological or metabolic disorders
Goods and ServicesScientific and technological services and research, in particular scientific research for identification, testing and characterisation of biological macromolecules; medical testing services, namely, pre-clinical and clinical testing of macromolecules; scientific research in the nature of discovery of biological macromolecules; Laboratory services, related to custom manufacturing of pharmaceutical ingredients, for identification, testing and characterisation of biological macromolecules

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, September 13, 2019
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, September 13, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 13, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 13, 2019
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCUREVAC SE
Party Type31 - New Owner After Registration
Legal Entity Type94 - NOT AVAILABLE
AddressTÜBINGEN 72076
DE

Party NameCureVac AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressTübingen 72076
DE

Party NameCureVac AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressTübingen 72076
DE

Party NameCureVac AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressTübingen 72076
DE

Trademark Events


Event DateEvent Description
Wednesday, March 8, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, September 30, 2021CORRECTION UNDER SECTION 7 ¿ PROCESSED
Thursday, September 30, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, April 30, 2021TEAS SECTION 7 REQUEST RECEIVED
Tuesday, April 13, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, January 26, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 26, 2021PUBLISHED FOR OPPOSITION
Wednesday, January 6, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, December 17, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 17, 2020EXAMINER'S AMENDMENT ENTERED
Thursday, December 17, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, December 17, 2020EXAMINERS AMENDMENT E-MAILED
Thursday, December 17, 2020EXAMINERS AMENDMENT -WRITTEN
Wednesday, December 16, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 16, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 15, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 30, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, June 30, 2020NON-FINAL ACTION E-MAILED
Tuesday, June 30, 2020NON-FINAL ACTION WRITTEN
Tuesday, June 16, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 16, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 15, 2020ASSIGNED TO LIE
Thursday, June 4, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 9, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, December 9, 2019NON-FINAL ACTION E-MAILED
Monday, December 9, 2019NON-FINAL ACTION WRITTEN
Thursday, December 5, 2019ASSIGNED TO EXAMINER
Saturday, September 14, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, September 13, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, September 6, 2019NEW APPLICATION ENTERED